AEON Biopharma (AEON) Q2 2024 Earnings
AEON·Reported August 12, 2024·Before market open
Diluted EPS came in at $-11.51, beat the $-13.67 consensus by $2.16.
Diluted EPS
$-11.51beat by $2.16
Consensus: $-13.67
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about AEON Biopharma's Q2 2024 earnings report.
AEON Biopharma (AEON) reported Q2 2024 earnings on August 12, 2024 before market open.
AEON Biopharma reported diluted EPS of $-11.51 for Q2 2024.
EPS beat the consensus estimate of $-13.67 by $2.16.
You can read the 10-Q periodic report (0001558370-24-011896) directly on SEC EDGAR. The filing index links above go to sec.gov.